Gillis A M
Division of Cardiology, Foothills Hospital, Calgary, Alberta, Canada.
Pacing Clin Electrophysiol. 1996 Oct;19(10):1459-68. doi: 10.1111/j.1540-8159.1996.tb03159.x.
The long-term costs of cardiac pacing include the device costs, the procedural costs, the follow-up costs, and the replacement costs. At present, there is significant variability in the efficiencies of the integrated circuits and the total battery capacity among different pulse generators that will influence replacement rates over time. Accordingly, we compared the influence of pulse generator longevity on the long-term costs of pacing. The longevity of pulse generators was calculated based on the electrical characteristics of the device and the percentage of time the patient is paced. Replacement rates of pulse generators were estimated for our patient population over a 20-year period, based on patient survival and pulse generator longevity. The costs of pacing over this 20-year follow-up period were then calculated. The longevity of DDDR devices presently implanted in the United States ranges from 8-14 years, assuming that patients are paced 50% of the time. Replacement rates in this population over a 20-year follow-up period were calculated to range from 0.34-0.66, and the total costs of pacing would range from $11,898-14,900 per patient. The longevity of SSIR devices ranges from 7-20 years, assuming that patients are paced 50% of the time. Replacement rates were calculated over the 20-year follow-up period to range from 0.20-0.84, and the total costs of VVIR pacing would range from $8,331-13,286. Based on the proportion of pulse generator models implanted in patients in the United States, the maximum cost differential to the health care system is approximately $424 million/year comparing the devices with the shortest and greatest longevities. Thus, pulse generator longevity may significantly influence the long-term costs of pacing. Patient survival and pulse generator system longevity should be considered when selecting the appropriate pacing system for the individual patient.
心脏起搏的长期成本包括设备成本、手术成本、随访成本和更换成本。目前,不同脉冲发生器的集成电路效率和总电池容量存在显著差异,这将随时间影响更换率。因此,我们比较了脉冲发生器使用寿命对起搏长期成本的影响。脉冲发生器的使用寿命是根据设备的电气特性和患者起搏时间的百分比来计算的。基于患者生存率和脉冲发生器使用寿命,估计了我们患者群体在20年期间的脉冲发生器更换率。然后计算了这20年随访期内的起搏成本。假设患者50%的时间处于起搏状态,目前在美国植入的DDDR设备的使用寿命为8至14年。计算出该人群在20年随访期内的更换率为0.34至0.66,每位患者的起搏总成本为11,898至14,900美元。假设患者50%的时间处于起搏状态,SSIR设备的使用寿命为7至20年。计算出20年随访期内的更换率为0.20至0.84,VVIR起搏的总成本为8,331至13,286美元。根据在美国患者中植入的脉冲发生器型号比例,将使用寿命最短和最长的设备进行比较,医疗保健系统的最大成本差异约为每年4.24亿美元。因此,脉冲发生器的使用寿命可能会显著影响起搏的长期成本。为个体患者选择合适的起搏系统时,应考虑患者生存率和脉冲发生器系统的使用寿命。